glp-1-appeals">Aetna Denied Diabetes Supplies? CGM, Insulin Pump, and GLP-1 Appeals

Diabetes management requires consistent access to supplies and medications — and Aetna denials for continuous glucose monitors (CGMs), insulin pumps, and GLP-1 receptor agonists are both common and reversible. Understanding Aetna's specific criteria for each category is the foundation of a successful appeal.

Continuous Glucose Monitor (CGM) Denials

Aetna covers CGMs (Dexcom G6/G7, FreeStyle Libre, Medtronic Guardian) as durable medical equipment (DME), subject to Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization. CVS Caremark handles the pharmacy side when CGM supplies are dispensed through pharmacy channels.

Aetna's CGM coverage criteria typically require:

• Type 1 or Type 2 diabetes diagnosis
• Current insulin therapy (multiple daily injections or insulin pump)
• Documentation of hypoglycemia unawareness, frequent hypoglycemic episodes, or difficulty achieving glycemic targets on standard monitoring
• Physician attestation that CGM is medically necessary

Aetna has historically limited CGM coverage to insulin-dependent diabetics, though coverage for non-insulin-using Type 2 patients is expanding due to clinical evidence and FDA approvals. If you were denied because you use oral medications or GLP-1s without insulin, cite the American Diabetes Association's Standards of Care supporting CGM use across diabetes management types.

CGM channel issue: CGMs are covered under either the medical benefit (DME) or pharmacy benefit depending on how they're dispensed. If your CGM was denied under one benefit, check whether it's covered under the other. Dexcom and Abbott have pharmacy programs that may offer different prior auth pathways.

Insulin Pump Denials

Aetna covers insulin pumps as DME for Type 1 diabetes patients who meet specific criteria under Aetna's Insulin Infusion Pump CPB:

• Type 1 diabetes diagnosis
• Failure to achieve adequate control with multiple daily injections (MDI)
• Willingness and ability to self-monitor blood glucose 4+ times daily
• Documented HbA1c above target despite MDI, or documented hypoglycemia unawareness
• Prescription from an endocrinologist (Aetna often requires this, not a general practitioner)

For Type 2 diabetes insulin pump coverage: Aetna applies additional restrictions, typically requiring demonstrated failure on MDI with high insulin requirements (often 80+ units per day) and endocrinology involvement.

If your pump was denied, obtain a detailed letter from your endocrinologist documenting your HbA1c history, hypoglycemic episodes (frequency, severity, requiring assistance), and why MDI is insufficient for your control.

ozempic-wegovy-mounjaro-trulicity">GLP-1 Receptor Agonist Denials (Ozempic, Wegovy, Mounjaro, Trulicity)

GLP-1 medications are among the most frequently denied prescriptions through Aetna/CVS Caremark. Common denial reasons:

For diabetes treatment (Ozempic, Trulicity, Victoza):

• Step therapy: Aetna/CVS Caremark may require metformin and/or a sulfonylurea first
• Non-preferred tier: the specific GLP-1 is not preferred on the formulary
• Prior authorization missing or incomplete

For obesity/weight management (Wegovy, Zepbound):

• Weight management drugs are often excluded from medical benefit coverage
• BMI criteria not met or not documented
• Comorbidity documentation insufficient

To appeal a GLP-1 denial for diabetes management, your prescriber should document:

• Prior use of metformin and reason for inadequacy or contraindication (renal function, GI intolerance)
• Cardiovascular risk (GLP-1s have proven CV benefits — cite the LEADER and SUSTAIN-6 trials for Victoza/Ozempic)
• HbA1c levels and target
• Why the preferred GLP-1 on Aetna's formulary is not appropriate (if requesting a non-preferred drug)

Diabetes Supply Prior Authorization Through CVS Caremark

For pharmacy-dispensed diabetes supplies, the prior authorization goes through CVS Caremark. Key contacts:

• CVS Caremark diabetes supply PA: 1-800-552-8159
• CVS Caremark exception line: 1-800-237-2767
• CVS Specialty (for specialty diabetes medications): 1-800-237-2767

For DME-benefit CGMs and pumps, the PA goes through Aetna directly. Use an in-network DME supplier enrolled with Aetna to minimize additional denial reasons.

How to Appeal Aetna Diabetes Supply Denials

Your appeal package should include:

1. Denial letter specifying the reason code and criterion not met
2. Physician letter of medical necessity addressing each criterion in Aetna's CPB
3. Lab results: HbA1c history (past 12 months), fasting glucose logs
4. Hypoglycemia log: Dates, severity, circumstances for each episode
5. Prior treatment records: Documentation of previous medications/supplies tried
6. ADA Standards of Care citations: Current year guidelines supporting your treatment

File your appeal:

• Phone: 1-800-537-9384
• Online: my.aetna.com
• Written: Aetna Appeals, P.O. Box 981106, El Paso, TX 79998

Fight Back With ClaimBack

Diabetes supply denials are among the most medically urgent — delays in CGM or insulin pump access can cause serious harm. ClaimBack helps you build a rapid, criteria-specific appeal using Aetna's own CPB language and ADA guidelines to support your case.

Start your Aetna diabetes supply appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied